Poly-N-acetyl glucosamine fibers induce angiogenesis in ADP inhibitor-treated diabetic mice

Journal of Trauma - Injury, Infection and Critical Care

Volumn 71, Issue 2 SUPPL. 1, 2011, Pages

  Scherer, Saja S ^b   Pietramaggiori, Giorgio ^b   Matthews, Jasmine C ^a   Gennaoui, Anthony ^e   Demcheva, Marina ^c   Fischer, Thomas H ^d   Valeri, C Robert ^e   Orgill, Dennis P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Marine Polymer Technologies   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e Naval Blood Research Laboratory Inc   (United States)

Author keywords

Angiogenesis; Clopidogrel; Diabetic wounds; Poly N acetyl glucosamine

Indexed keywords

CD31 ANTIGEN; CLOPIDOGREL; KI 67 ANTIGEN; NANOFIBER; POLY N ACETYL GLUCOSAMINE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; N ACETYLGLUCOSAMINE; POLY-N-ACETYL GLUCOSAMINE; PURINERGIC P2Y RECEPTOR ANTAGONIST; TICLOPIDINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ARTICLE; BLOOD VESSEL; CELL PROLIFERATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DENSITY; DIABETES MELLITUS; ELECTRON MICROSCOPY; GAMMA RADIATION; GRANULATION TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INJURY; WOUND CARE; WOUND HEALING; ANIMAL; C57BL MOUSE; DRUG EFFECT; INJURY; PATHOLOGY; PATHOPHYSIOLOGY;

ACETYLGLUCOSAMINE; ANIMALS; DIABETES COMPLICATIONS; MALE; MICE; MICE, INBRED C57BL; NANOFIBERS; NEOVASCULARIZATION, PHYSIOLOGIC; PURINERGIC P2Y RECEPTOR ANTAGONISTS; TICLOPIDINE; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84863659938     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318225585b     Document Type: Article

References (16)

1. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382-387. (Pubitemid 29106890)
2. Ahroni JH, Boyko EJ, Forsberg RC. Clinical correlates of plantar pressure among diabetic veterans. Diabetes Care. 1999;22:965-972. (Pubitemid 29241053)
3. Niruntraporn S, Chaiyakunapruk N, Nathisuwan S, Thamlikitkul V. Utilisation review of clopidogrel: are they used under the FDA-approved indications? Pharmacoepidemiol Drug Saf. 2007;16:1031-1037. (Pubitemid 47430382)
4. Pietramaggiori G, Kaipainen A, Czeczuga JM, Wagner CT, Orgill DP. Freeze-dried platelet-rich plasma shows beneficial healing properties in chronic wounds. Wound Repair Regen. 2006;14:573-580. (Pubitemid 44470074)
5. Pietramaggiori G, Kaipainen A, Ho D, et al. Trehalose lyophilized platelets for wound healing. Wound Repair Regen. 2007;15:213-220. (Pubitemid 46376382)
6. Kisucka J, Butterfield CE, Duda DG, et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci USA. 2006;103:855-860. (Pubitemid 43212187)
7. Italiano JE Jr, Richardson JL, Patel-Hett S, et al. Angiogenesis is regulated by a novel mechanism: pro- and anti-angiogenic proteins are organized into separate platelet {alpha}-granules and differentially released. Blood. 2008;111:1227-1233. (Pubitemid 351213404)
8. Eppley BL, Pietrzak WS, Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg. 2006; 118:147e-159e. (Pubitemid 44610374)
9. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg. 2006;117(7 Suppl):143S-149S; discussion 150S-151S. (Pubitemid 44317778)
10. Driver VR, Hanft J, Fylling CP, Beriou JM; Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006;52:68 -70, 72, 74 passim.
11. Scherer SS, Pietramaggiori G, Matthews J, et al. Poly-N-acetyl glucosamine nanofibers: a new bioactive material to enhance diabetic wound healing by cell migration and angiogenesis. Ann Surg. 2009;250:322-330.
12. Pietramaggiori G, Yang HJ, Scherer SS, et al. Effects of poly-N-acetyl glucosamine (pGlcNAc) patch on wound healing in db/db mouse. J Trauma. 2008;64:803-808. (Pubitemid 351366913)
13. Fischer TH, Thatte HS, Nichols TC, Bender-Neal DE, Bellinger AD, Vournakis JN. Synergistic platelet integrin signaling and factor XII activation in poly-N-acetyl glucosamine fiber-mediated hemostasis. Biomaterials. 2005;26:5433-5443. (Pubitemid 40592133)
14. Vournakis JN, Eldridge J, Demcheva M, Muise-Helmericks RC. Poly- N-acetyl glucosamine nanofibers regulate endothelial cell movement and angiogenesis: dependency on integrin activation of Ets1. J Vasc Res. 2008;45:222-232. (Pubitemid 351543146)
15. Abele S, Weyand M, Wollin M, et al. Clopidogrel reduces the development of transplant arteriosclerosis. J Thorac Cardiovasc Surg. 2006;131:1161-1166.
16. Pietramaggiori G, Scherer SS, Mathews JC, et al. Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Wound Repair Regen. 2008;16:218-225. (Pubitemid 351342131)